Drug companies are using women of colour and First Nations celebrities in weight-loss campaigns. Not everyone’s happy.
Articles on GLP-1
Displaying 1 - 20 of 42 articles
GLP-1 drugs can produce major weight loss, but their wider impact will depend on affordable treatment and appropriate support.
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.
Many people regain weight after stopping GLP-1 medicines. Long-term support may be as important as the drugs themselves.
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
Grey-market peptides are becoming mainstream, but evidence of their effectiveness is thin or non-existent.
In a clinical trial, this small-molecule drug was found to be superior to semaglutide for lowering blood sugar.
GLP-1 drugs like Ozempic and Wegovy aid in weight loss by suppressing appetite. Researchers are looking next at how the body expends energy – including through fat.
GLP-1 drugs are the first medication to show promise for treating addiction to a wide range of substances.
Appetite is governed by gut hormones, not willpower. GLP-1 therapies extend natural satiety signals and expose the biology behind eating.
As GLP-1 medications surge in popularity, companies are selling tailored supplements. Science suggests most people do not need them.
Before you spend your money, here’s why you should think twice about buying a weight-loss patch.
Due to the body’s natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.
Firms will add new products to their ranges – but they’re unlikely to abandon reliable profits from unhealthy foods.
Drugs such as Ozempic and Wegovy reduce hunger and help with weight loss – but long-term use can make nutrient deficiencies more likely.
Millions are taking weight loss drugs like Wegovy. But what happens when you stop? Eggs might help fill the gap.
High prescription drug costs are leaving many patients frustrated and unable to afford their medications.
Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in those taking Ozempic, Wegovy and Mounjaro.
Two major trials show the weight-loss drug offers no cognitive benefit to people with early Alzheimer’s, dashing hopes it might protect the brain.
Additional policy changes can help change key factors that drive obesity.
Top contributors
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Clinical Epidemiologist, Washington University in St. Louis
-
General Practitioner, PhD Candidate, Bond University
-
Accredited Practising Dietitian and Lecturer, Southern Cross University
-
Associate Professor of Medical Education, University of Nottingham; University of Lincoln
-
Head of the Translational Nanomedicine & Biotherapeutics Group and Senior Research Fellow, Adelaide University
-
Professor of Community Health and Wellbeing, The University of Queensland
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Professor, Kinesiology, Tier 1 Canada Research Chair in Skeletal Muscle Health, McMaster University
-
Postdoctoral Research Fellow, Edge Hill University
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Professor of Law, Villanova University
-
Senior Research Fellow, Florey Institute of Neuroscience and Mental Health
-
Lecturer Pharmacy Practice, University of Sydney
-
Addiction Psychiatrist, Associate Professor, Monash University